Total Payments
$44,796
2024 Payments
$88.79
Companies
6
Transactions
70
Medicare Patients
343
Medicare Billing
$24,748
Payment Breakdown by Category
Travel$33,507 (74.8%)
Other$3,410 (7.6%)
Food & Beverage$3,231 (7.2%)
Research$3,000 (6.7%)
Consulting$1,649 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $33,507 | 36 | 74.8% |
| Food and Beverage | $3,231 | 25 | 7.2% |
| Unspecified | $3,000 | 1 | 6.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,355 | 3 | 5.3% |
| Consulting Fee | $1,649 | 3 | 3.7% |
| Honoraria | $1,055 | 2 | 2.4% |
Payments by Type
General
$41,796
69 transactions
Research
$3,000
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optos Plc | $41,515 | 63 | $0 (2020) |
| Astellas Pharma Global Development | $3,000 | 1 | $0 (2023) |
| Alimera Sciences, Inc. | $109.68 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $79.42 | 1 | $0 (2019) |
| NotalVision | $48.69 | 1 | $0 (2017) |
| Regeneron Pharmaceuticals, Inc. | $42.79 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88.79 | 2 | Alimera Sciences, Inc. ($88.79) |
| 2023 | $3,000 | 1 | Astellas Pharma Global Development ($3,000) |
| 2022 | $20.89 | 1 | Alimera Sciences, Inc. ($20.89) |
| 2020 | $11,368 | 14 | Optos Plc ($11,368) |
| 2019 | $14,842 | 22 | OPTOS PLC ($14,763) |
| 2018 | $13,293 | 21 | OPTOS PLC ($13,293) |
| 2017 | $2,184 | 9 | OPTOS PLC ($2,092) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $56.77 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 01/30/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/17/2023 | Astellas Pharma Global Development | Izervay (Drug) | — | Cash or cash equivalent | $3,000.00 | Research |
| Study: A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura (Complement C5 Inhibitor) Compared to Sham in Subjects with Autosomal Recessive Stargardt Disease • Category: Ophthalmology | ||||||
| 12/19/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Travel and Lodging | Cash or cash equivalent | $2,741.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Travel and Lodging | Cash or cash equivalent | $2,720.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Travel and Lodging | Cash or cash equivalent | $2,493.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Travel and Lodging | Cash or cash equivalent | $1,403.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Honoraria | Cash or cash equivalent | $800.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Food and Beverage | Cash or cash equivalent | $344.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Honoraria | Cash or cash equivalent | $255.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Travel and Lodging | Cash or cash equivalent | $135.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Travel and Lodging | Cash or cash equivalent | $100.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Travel and Lodging | Cash or cash equivalent | $100.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Food and Beverage | Cash or cash equivalent | $97.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Food and Beverage | Cash or cash equivalent | $72.49 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Travel and Lodging | Cash or cash equivalent | $64.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Optos Plc | P200DTx (Device), P200T, P200TE | Food and Beverage | Cash or cash equivalent | $40.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/12/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | Cash or cash equivalent | $79.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/20/2019 | OPTOS PLC | — | Travel and Lodging | In-kind items and services | $3,432.24 | General |
| 03/20/2019 | OPTOS PLC | — | Travel and Lodging | In-kind items and services | $3,048.66 | General |
| 03/20/2019 | OPTOS PLC | — | Travel and Lodging | In-kind items and services | $2,057.09 | General |
| 03/20/2019 | OPTOS PLC | — | Travel and Lodging | In-kind items and services | $1,309.33 | General |
| 03/20/2019 | OPTOS PLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,029.60 | General |
| 03/20/2019 | OPTOS PLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $675.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura (Complement C5 Inhibitor) Compared to Sham in Subjects with Autosomal Recessive Stargardt Disease | Astellas Pharma Global Development | $3,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 69 | 88 | $14,948 | $3,212 |
| 2021 | 4 | 129 | 173 | $33,265 | $8,793 |
| 2020 | 3 | 145 | 223 | $56,793 | $12,743 |
Total Patients
343
Total Services
484
Medicare Billing
$24,748
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 32 | 36 | $7,920 | $1,471 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 16 | $2,384 | $880.28 | 36.9% |
| 92134 | Imaging of retina | Office | 2022 | 24 | 36 | $4,644 | $860.30 | 18.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 35 | 45 | $9,900 | $2,780 | 28.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 36 | $5,364 | $2,456 | 45.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 40 | 68 | $10,297 | $2,128 | 20.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 23 | 24 | $7,704 | $1,429 | 18.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 84 | 103 | $33,063 | $8,338 | 25.2% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 46 | 89 | $16,910 | $2,277 | 13.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 15 | 31 | $6,820 | $2,127 | 31.2% |
About Thomas Friberg
Thomas Friberg is a Ophthalmology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225001969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Friberg has received a total of $44,796 in payments from pharmaceutical and medical device companies, with $88.79 received in 2024. These payments were reported across 70 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($33,507).
As a Medicare-enrolled provider, Friberg has provided services to 343 Medicare beneficiaries, totaling 484 services with total Medicare billing of $24,748. Data is available for 3 years (2020–2022), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Pittsburgh, PA
- Active Since 02/13/2006
- Last Updated 03/25/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1225001969
Products in Payments
- P200DTx (Device) $11,368
- Izervay (Drug) $3,000
- YUTIQ (Drug) $88.79
- BEOVU (Drug) $79.42
- ForeseeHome (Device) $48.69
- EYLEA AFLIBERCEPT INJECTION (Biological) $42.79
- ILUVIEN (Drug) $20.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Pittsburgh
Ian Conner
Ophthalmology — Payments: $185,122
Ophthalmology $185,122
Dr. Srinivas Kondapalli, M.d, M.D
Ophthalmology — Payments: $164,682
Ophthalmology $164,682
Deval Paranjpe, Md, MD
Ophthalmology — Payments: $96,451
Ophthalmology $96,451
Dr. Omar Abbasi, Md, MD
Ophthalmology — Payments: $75,475
Ophthalmology $75,475
Dr. Nils Loewen, M.d., Ph.d, M.D., PH.D
Ophthalmology — Payments: $62,838
Ophthalmology $62,838
Jenny Yu
Ophthalmology — Payments: $47,258
Ophthalmology $47,258